Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Risk factors for Staphylococcus aureus bacteremia in patients with rheumatoid arthritis and incidence compared with the general population: protocol for a Danish nationwide observational cohort study.

Dieperink SS, Glintborg B, Oestergaard LB, Nørgaard M, Benfield T, Mehnert F, Petersen A, Hetland ML.

BMJ Open. 2019 Sep 3;9(9):e030999. doi: 10.1136/bmjopen-2019-030999.

2.

Comparative effectiveness of certolizumab pegol, abatacept and biosimilar infliximab in patients with rheumatoid arthritis treated in routine care. Observational data from the Danish DANBIO registry emulating a randomized trial.

Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Østergaard M, Dreyer L, Krogh NS, Bjorner JB, Hetland ML.

Arthritis Rheumatol. 2019 Jul 3. doi: 10.1002/art.41031. [Epub ahead of print]

PMID:
31268624
3.

Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al.

Glintborg B, Loft AG, Omerovic E, Hendricks O, Linauskas A, Espesen J, Danebod K, Jensen DV, Nordin H, Dalgaard EB, Chrysidis S, Kristensen S, Raun JL, Lindegaard H, Manilo N, Jakobsen SH, Hansen IMJ, Pedersen DD, Sørensen IJ, Andersen LS, Grydehøj J, Mehnert F, Krogh NS, Lund Hetland M.

Ann Rheum Dis. 2019 Jan 23. pii: annrheumdis-2018-214952. doi: 10.1136/annrheumdis-2018-214952. [Epub ahead of print] No abstract available.

PMID:
30674476
4.

Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden.

Grøn KL, Arkema EV, Glintborg B, Mehnert F, Østergaard M, Dreyer L, Nørgaard M, Krogh NS, Askling J, Hetland ML; ARTIS Study Group.

Ann Rheum Dis. 2019 Mar;78(3):320-327. doi: 10.1136/annrheumdis-2018-214326. Epub 2019 Jan 5.

PMID:
30612115
5.

Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci.

Glintborg B, Loft AG, Omerovic E, Hendricks O, Linauskas A, Espesen J, Danebod K, Jensen DV, Nordin H, Dalgaard EB, Chrysidis S, Kristensen S, Raun JL, Lindegaard H, Manilo N, Jakobsen SH, Hansen IMJ, Dalsgaard Pedersen D, Sørensen IJ, Andersen LS, Grydehøj J, Mehnert F, Krogh NS, Hetland ML.

Ann Rheum Dis. 2018 Dec 20. pii: annrheumdis-2018-214788. doi: 10.1136/annrheumdis-2018-214788. [Epub ahead of print] No abstract available.

PMID:
30573653
6.

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program.

Mikkelsen EM, Thomsen MK, Tybjerg J, Friis-Hansen L, Andersen B, Jørgensen JCR, Baatrup G, Njor SH, Mehnert F, Rasmussen M.

Clin Epidemiol. 2018 Nov 13;10:1649-1655. doi: 10.2147/CLEP.S181204. eCollection 2018.

7.

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry.

Glintborg B, Loft AG, Omerovic E, Hendricks O, Linauskas A, Espesen J, Danebod K, Jensen DV, Nordin H, Dalgaard EB, Chrysidis S, Kristensen S, Raun JL, Lindegaard H, Manilo N, Jakobsen SH, Hansen IMJ, Dalsgaard Pedersen D, Sørensen IJ, Andersen LS, Grydehøj J, Mehnert F, Krogh NS, Hetland ML.

Ann Rheum Dis. 2019 Feb;78(2):192-200. doi: 10.1136/annrheumdis-2018-213474. Epub 2018 Nov 5.

PMID:
30396903
8.

Cervical screening in Denmark - a success followed by stagnation.

Lynge E, Andersen B, Christensen J, Ejersbo D, Jochumsen K, Johansen T, Kristensen JK, Larsen LG, Mehnert F, Mikkelsen E, Nielsen K, Rygaard C, Serizawa R, Waldstrøm M.

Acta Oncol. 2018 Mar;57(3):354-361. doi: 10.1080/0284186X.2017.1355110. Epub 2017 Aug 23.

PMID:
28835155
9.

Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention.

Jakobsen L, Terkelsen CJ, Christiansen EH, Maeng M, Jensen LO, Veien K, Raungaard B, Jensen SE, Mehnert F, Johnsen SP.

Am J Cardiol. 2017 Aug 15;120(4):550-555. doi: 10.1016/j.amjcard.2017.05.021. Epub 2017 May 30.

PMID:
28645474
10.

Lifetime Risk of Primary Total Hip Replacement Surgery for Osteoarthritis From 2003 to 2013: A Multinational Analysis Using National Registry Data.

Ackerman IN, Bohensky MA, de Steiger R, Brand CA, Eskelinen A, Fenstad AM, Furnes O, Graves SE, Haapakoski J, Mäkelä K, Mehnert F, Nemes S, Overgaard S, Pedersen AB, Garellick G.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1659-1667. doi: 10.1002/acr.23197. Epub 2017 Sep 26.

11.

Substantial rise in the lifetime risk of primary total knee replacement surgery for osteoarthritis from 2003 to 2013: an international, population-level analysis.

Ackerman IN, Bohensky MA, de Steiger R, Brand CA, Eskelinen A, Fenstad AM, Furnes O, Garellick G, Graves SE, Haapakoski J, Havelin LI, Mäkelä K, Mehnert F, Pedersen AB, Robertsson O.

Osteoarthritis Cartilage. 2017 Apr;25(4):455-461. doi: 10.1016/j.joca.2016.11.005. Epub 2016 Nov 14.

12.

The database of the Danish Renal Cancer Group.

Petersen AC, Søgaard M, Mehnert F, Larsen EH, Donskov F, Azawi NH, Kromann-Andersen B.

Clin Epidemiol. 2016 Oct 25;8:725-729. eCollection 2016. Review.

13.

Reply to 'Adjusting for Ethnicity'.

Schmidt SA, Schmidt M, Mehnert F, Lemeshow S, Sørensen HT.

J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e167. doi: 10.1111/jdv.13471. Epub 2015 Nov 9. No abstract available.

PMID:
26549186
14.

Age- and sex-related differences in use of guideline-recommended care and mortality among patients with incident heart failure in Denmark.

Nakano A, Egstrup K, Svendsen ML, Schjødt I, Jakobsen L, Mehnert F, Johnsen SP.

Age Ageing. 2016 Sep;45(5):635-42. doi: 10.1093/ageing/afw119. Epub 2016 Jul 18.

PMID:
27496924
15.

Rheumatoid Arthritis: Trends in Antirheumatic Drug Use, C-reactive Protein Levels, and Surgical Burden.

Pedersen AB, Mor A, Mehnert F, Thomsen RW, Johnsen SP, Nørgaard M.

J Rheumatol. 2015 Dec;42(12):2247-54. doi: 10.3899/jrheum.141297. Epub 2015 Nov 1.

PMID:
26523019
16.

Use of antihypertensive drugs and risk of skin cancer.

Schmidt SA, Schmidt M, Mehnert F, Lemeshow S, Sørensen HT.

J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1545-54. doi: 10.1111/jdv.12921. Epub 2015 Jan 15.

PMID:
25640031
17.

Effectiveness and safety of different duration of thromboprophylaxis in 16,865 hip replacement patients--a real-word, prospective observational study.

Pedersen AB, Sorensen HT, Mehnert F, Johnsen SP, Overgaard S.

Thromb Res. 2015 Feb;135(2):322-8. doi: 10.1016/j.thromres.2014.11.029. Epub 2014 Dec 3.

PMID:
25511580
18.

Is the use of oral contraceptives associated with operatively treated anterior cruciate ligament injury? A case-control study from the Danish Knee Ligament Reconstruction Registry.

Rahr-Wagner L, Thillemann TM, Mehnert F, Pedersen AB, Lind M.

Am J Sports Med. 2014 Dec;42(12):2897-905. doi: 10.1177/0363546514557240.

PMID:
25428957
19.

Hydroxyapatite coating does not improve uncemented stem survival after total hip arthroplasty!

Hailer NP, Lazarinis S, Mäkelä KT, Eskelinen A, Fenstad AM, Hallan G, Havelin L, Overgaard S, Pedersen AB, Mehnert F, Kärrholm J.

Acta Orthop. 2015 Feb;86(1):18-25. doi: 10.3109/17453674.2014.957088. Epub 2014 Sep 1.

20.

The risk of venous thromboembolism, myocardial infarction, stroke, major bleeding and death in patients undergoing total hip and knee replacement: a 15-year retrospective cohort study of routine clinical practice.

Pedersen AB, Mehnert F, Sorensen HT, Emmeluth C, Overgaard S, Johnsen SP.

Bone Joint J. 2014 Apr;96-B(4):479-85. doi: 10.1302/0301-620X.96B4.33209.

PMID:
24692614

Supplemental Content

Loading ...
Support Center